BioSpace News Archive

Applied Molecular Transport (Nasdaq: AMTI), a clinical-stage biopharmaceutical company, today announced the pricing of its initial public offering of 11,000,000 shares of common stock at a public offering price of $14.00 per share.

Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXv: GSD), a clinical stage botanical pharmaceutical company, focused on developing a unique portfolio of botanical pharmaceutical and cosmeceutical products, today announced a Strategic Alliance with CannTx Life Sciences Inc. (“CannTx”), a privately-owned cannabis producer licensed by Health Canada under the Cannabis Act

The COVID-19 epidemic has left the world devastated, with over 350,000 dead and the global economy in shambles in just 5 months.

Neovasc Inc. (“Neovasc” or the “Company”) ( NASDAQ , TSX : NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies, and minimally invasive devices for the treatment of refractory angina, announced today that, further to its press release dated May 26, 2020, the Company has issued a final convertible note in the principal amount US$1 million to Strul

OncoSec Medical Incorporated (NASDAQ:ONCS) (the “Company” or “OncoSec”), a company developing late-stage intratumoral cancer immunotherapies, today announced that Daniel J. O’Connor , President and Chief Executive Officer of OncoSec, will present a company overview at the Virtual Summer Investor Summit on Tuesday, J

Global leaders unite to safeguard 300 million more children from disease and mitigate consequences of COVID-19

In light of the ongoing COVID-19 pandemic, the U.S. Bankruptcy Court for the Southern District of New York has granted a 30-day extension of the deadline to file a claim against Purdue Pharma L.P.,1 including claims related to Purdue prescription opioids, like OxyContin.2 The new deadline or “bar date” is Thursday, July 30, 2020, at 5:00 p.m..

Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced that David Schlanger, Progyny’s Chief Executive Officer, and Pete Anevski, President, Chief Financial and Operating Officer, will participate in a fireside chat at the Goldman Sachs 41st Annual Global Healthcare Conference on Tuesday, June 9, 2020 at 4:40 P.M. Eastern Time.

Rising cases of needle stick injuries, the shift in demand towards ambulatory surgical centers and fusion pumps, and a greater number of surgical procedures performed are poised to benefit the IV equipment market.

Strong consolidated financial position as at March 31, 2020 and strengthened since year-end